REQUEST A DEMO
Total
USD $0.00
Search more companies

GEMIL PHARMA Zrt (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: GEMIL PHARMA Zrt Profile Updated: August 16, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

GEMIL PHARMA Zrt is an enterprise based in Hungary. Its main office is in Budapest. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on June 12, 2018. 9 (2023) employees currently work for GEMIL PHARMA Zrt. From the latest financial highlights, GEMIL PHARMA Zrt reported a net sales revenue drop of 5.58% in 2022. There was a total growth of 16.39% in GEMIL PHARMA Zrt’s total assets over the same period. The net profit margin of GEMIL PHARMA Zrt increased by 20.36% in 2022.

Headquarters
Furj utca 2.
Budapest; Budapest; Postal Code: 1124

Contact Details: Purchase the GEMIL PHARMA Zrt report to view the information.

Website: http://www.gemilpharma.com

Basic Information
Total Employees:
Purchase the GEMIL PHARMA Zrt report to view the information.
Outstanding Shares:
Purchase the GEMIL PHARMA Zrt report to view the information.
Registered Capital:
Purchase the GEMIL PHARMA Zrt report to view the information.
Financial Auditors:
Purchase the GEMIL PHARMA Zrt report to view the information.
Incorporation Date:
June 12, 2018
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
16.67%
Purchase this report to view the information.
16.67%
Purchase this report to view the information.
16.66%
Company Performance
Financial values in the chart are available after GEMIL PHARMA Zrt report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-5.58%
Total operating revenue
-5.46%
Operating profit (EBIT)
23.94%
EBITDA
29.58%
Net Profit (Loss) for the Period
16.42%
Total assets
16.39%
Total equity
N/A
Operating Profit Margin (ROS)
33.28%
Net Profit Margin
20.36%
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
-0.06%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?